Inside the Qatar Genome Programme. The 2022 Phase One Mbarek paper that found 88 million variants in 6,047 Qataris, with 24 million novel. The 2024 Elfatih follow-up showing 3.5% of Qataris carry ACMG-actionable variants. The Q-Chip and the new pan-Arab array. And how the 96 percent Qatar share of Arab GWAS connects to the global equity question.